BIOSENSE TECHNOLOGIES, INC.

Address

4 ARROW DR
WOBURN, MA, 01801-2040

Information

DUNS: 122648533
# of Employees: 3

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N

Award Charts




Award Listing

  1. Rapid Testing of Drug Resistant BCR-ABL(+) Leukemia Cells

    Amount: $1,020,897.00

    DESCRIPTION (provided by applicant): Resistance to chemotherapeutic drugs is an ongoing problem that results in eventual treatment failures or suboptimal patient outcomes. Approximately one-quarter of ...

    SBIRPhase II2013Department of Health and Human Services
  2. Rapid Testing of Drug-Resistant BCR-ABL(+)Leukemia Cells

    Amount: $199,691.00

    DESCRIPTION (provided by applicant): Resistance to chemotherapeutic drugs is an ongoing problem that results in eventual treatment failures or suboptimal patient outcomes. In cancer cells treated with ...

    SBIRPhase I2011Department of Health and Human Services
  3. Diagnosis of Extra-Pulmonary Tuberculosis in HIV Patients

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): The diagnosis of tuberculosis (TB) in individuals co-infected with human immunodeficiency virus is significantly challenged by the increased prevalence of extra-p ...

    SBIRPhase I2008Department of Health and Human Services
  4. Rapid Diagnostic Testing of Urinary Tract Infections

    Amount: $750,000.00

    DESCRIPTION (provided by applicant): Abstract The continued development of a rapid diagnostic method for testing the antibiotic susceptibility of urinary tract infections in near real- ...

    SBIRPhase II2008Department of Health and Human Services
  5. SBIR Phase II: Early Growth Metabolic Responses of Mycobacteria

    Amount: $429,080.00

    This SBIR Phase II research project develops a new rapid, nonmolecular method for quickly testing the drug susceptibility of Mycobacteria tuberculosis, the bacterium causing the epidemic disease tuber ...

    SBIRPhase II2008National Science Foundation
  6. Rapid Diagnostic Testing of Urinary Tract Infections

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): The development of a new rapid diagnostic method for testing the antibiotic susceptibility of urinary tract infections is proposed. The technical approach is based ...

    SBIRPhase I2006Department of Health and Human Services
  7. SBIR Phase I: Early Growth Metabolic Responses of Mycobacteria

    Amount: $100,000.00

    This Small Business Innovation Research Phase I project describes a method for the drug susceptibility testing of mycobacteria having speed and simplicity. The technical approach is based on a novel i ...

    SBIRPhase I2006National Science Foundation
  8. SBIR Phase I: Rapid Antibiotic Suceptibility Testing of Sexually Transmitted Infections

    Amount: $100,000.00

    This Small Business Innovation Research (SBIR) Phase I project proposes the development of a new test to diagnose pathogenic microorganisms causing sexually transmitted infections at the point-of-care ...

    SBIRPhase I2006National Science Foundation
  9. Rapid Detection of Bacterial Contamination in Platelets

    Amount: $48,595.00

    DESCRIPTION (provided by applicant): The development of a rapid and simple method for the diagnostic testing of pathogenic bacteria in platelet products is proposed. The technical approach is based on ...

    SBIRPhase I2005Department of Health and Human Services
  10. Rapid Antibiotic Susceptibility Testing

    Amount: $476,168.00

    DESCRIPTION (provided by applicant): The development of a new method for the diagnostic testing of Mycobacterium tuberculosis having unparalleled speed and simplicity is proposed. The technical appro ...

    SBIRPhase I2003Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government